Company Name:Solid Biosciences Inc.
CEO: Ilan Ganot

Sector: Healthcare

Exchange: Nasdaq Global Select

Country: USA

Description: Solid Biosciences Inc is a life science company engaged in developing therapies for Duchenne muscular dystrophy. Its product candidate, SGT-001, is a gene transfer under development to restore functional dystrophin protein expression in patients' muscles.


Key numbers

Market Capitalization:143279877
Shares Outstanding: 46070700
Float: 28865966
Next Earning Date:2020-08-07
TTm EPS: -2.6826
TTm Dividend Rate:
200 days moving average:4.88
50 days moving average: 2.86
One day percent Change: 2.74



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,